{
  "id": 12449,
  "url": "https://www.ft.com/content/d75ca6b2-46f5-4343-a364-21a4440f5197?syn-25a6b1a6=1",
  "title": "Investors bet on AI drug discovery despite approval gap",
  "summary": "US specialist venture firm Dimension Capital raises $800mn fund to back AI-designed medicines",
  "authors": null,
  "category": "news",
  "topics": "healthcare,finance-investment,biotech",
  "orgs": null,
  "regions": null,
  "published_at": "2026-07-21T04:00:20.000Z",
  "fetched_at": "2026-07-22T05:10:49.469Z",
  "source_slug": "x-financial-times-technology-headlines",
  "source_name": "Financial Times Technology (headlines)",
  "source_homepage": "https://www.ft.com/technology",
  "ethics_ai_record_url": "https://ethics.ai/record/12449",
  "original_url": "https://www.ft.com/content/d75ca6b2-46f5-4343-a364-21a4440f5197?syn-25a6b1a6=1",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}